Regulatory tracker
UK peptide regulation: monthly overview
Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)
Last updated:
15 items in the 35 days to 2026-10-02, 15 new since the previous run. This combines the MHRA's own published feed with one monthly web-search pass for ASA rulings, Trading Standards action and named-retailer enforcement, the things no regulator RSS feed reliably carries. It is a reporting record, not advice.
15
Items in this run
15
New since previous run
3
Distinct sources
This month, by source
Every item below restates a published source with a direct link. Nothing is paraphrased from secondary reporting.
| Date | Source | Item |
|---|---|---|
| 2026-10-01 | MHRA announcement | MHRA joins global regulators in call to advance alternatives to animal testing International statement co-developed by UK medicines regulator |
| 2026-09-30 | MHRA announcement | DIA and MHRA announce speaker line-up for inaugural global summit International leaders will gather to address some of the most significant opportunities and challenges facing healthcare today at the DIA-MHRA Global Summit. |
| 2026-09-24 | MHRA announcement | MHRA welcomes sentencing after fraud convictions over falsely certified medical devices Following convictions related to falsely certified medical devices, the MHRA has welcomed the sentencing in a long-running enforcement investigation. |
| 2026-09-24 | MHRA announcement | Five new commissioners appointed to the Commission on Human Medicines (CHM) The CHM provides independent expert advice to ministers on the safety, quality and efficacy of medicines. |
| 2026-09-24 | MHRA announcement | Professor Dame Anna Dominiczak, Professor Alison Strath, and Fiona Cochrane: Catalysing the medicines ecosystem in Scotland Scotland’s growing commercial research infrastructure and strong NHS, academic and industry partnerships are helping widen access to clinical trials, accelerate adoption and strengthen the UK life sciences ecosystem. |
| 2026-09-23 | MHRA announcement | MHRA approves lurbinectedin for adults with extensive-stage small cell lung cancer As with all licensed medicines, the MHRA will keep the safety and effectiveness of lurbinectedin under close review. |
| 2026-09-22 | MHRA announcement | Funding opportunity launched to strengthen UK regulatory science and support healthcare innovation Four new centres of excellence will bring together expertise across academia, industry, healthcare and regulation to keep pace with advances in healthcare and life sciences |
| 2026-09-16 | MHRA announcement | MHRA sets out steps to prevent avoidable harm from patient hoists A National Patient Safety Alert has been issued setting out practical steps to reduce the risk of harm when using patient hoists through improved checks and maintenance. |
| 2026-09-15 | MHRA announcement | MHRA and Malaysia strengthen partnership on healthcare innovation and research The MHRA has reaffirmed its commitment to strengthening regulatory collaboration with Malaysia following high-level discussions in Kuala Lumpur. |
| 2026-09-10 | MHRA announcement | Independent Commission led by NHS doctors sets out blueprint to accelerate safe AI adoption in healthcare New recommendations based on extensive public engagement set out how the NHS could give patients faster access to AI advances with proportionate safeguards to protect patient safety and maintain high levels of trust. |
| 2026-09-02 | ASA | ASA ruling on SheMed Ltd The ASA ruled on a paid-for Reddit ad for SheMed, a female-focused medical weight-loss service, which promoted weight-loss prescription-only medicines to the public. A separate summary of the same ruling says it also covered emails and found the ads socially irresponsible, but only the Reddit ad description was confirmed on the ASA rulings listing. |
| 2026-09-02 | MHRA Drug Safety Update | Filters should be used during the administration of Parenteral Nutrition for patients in all care settings Administration of parenteral nutrition without a filter has been associated with a number of adverse incidents including an embolism which resulted in a fatal outcome. |
| 2026-09-02 | MHRA announcement | MHRA and Manchester NHS partner on health innovation sandbox New partnership to create health innovation sandbox that will test promising new technologies and build evidence to accelerate the safe adoption of technologies, including AI, in the NHS. |
| 2026-09-01 | MHRA announcement | MHRA concludes review of Avacopan Vifor following reassessment of benefit-risk balance Avacopan Vifor is used in the treatment of some rare autoimmune diseases affecting small blood vessels. |
| 2026-09-01 | MHRA announcement | MHRA regulatory reform amendments tabled in Government’s Health Bill Proposed amendments to support information sharing, regulatory reform and the future development of a medical device licensing regime. |
| Date | Source | Item | Summary |
|---|---|---|---|
| 2026-10-01 | MHRA announcement | MHRA joins global regulators in call to advance alternatives to animal testing | International statement co-developed by UK medicines regulator |
| 2026-09-30 | MHRA announcement | DIA and MHRA announce speaker line-up for inaugural global summit | International leaders will gather to address some of the most significant opportunities and challenges facing healthcare today at the DIA-MHRA Global Summit. |
| 2026-09-24 | MHRA announcement | MHRA welcomes sentencing after fraud convictions over falsely certified medical devices | Following convictions related to falsely certified medical devices, the MHRA has welcomed the sentencing in a long-running enforcement investigation. |
| 2026-09-24 | MHRA announcement | Five new commissioners appointed to the Commission on Human Medicines (CHM) | The CHM provides independent expert advice to ministers on the safety, quality and efficacy of medicines. |
| 2026-09-24 | MHRA announcement | Professor Dame Anna Dominiczak, Professor Alison Strath, and Fiona Cochrane: Catalysing the medicines ecosystem in Scotland | Scotland’s growing commercial research infrastructure and strong NHS, academic and industry partnerships are helping widen access to clinical trials, accelerate adoption and strengthen the UK life sciences ecosystem. |
| 2026-09-23 | MHRA announcement | MHRA approves lurbinectedin for adults with extensive-stage small cell lung cancer | As with all licensed medicines, the MHRA will keep the safety and effectiveness of lurbinectedin under close review. |
| 2026-09-22 | MHRA announcement | Funding opportunity launched to strengthen UK regulatory science and support healthcare innovation | Four new centres of excellence will bring together expertise across academia, industry, healthcare and regulation to keep pace with advances in healthcare and life sciences |
| 2026-09-16 | MHRA announcement | MHRA sets out steps to prevent avoidable harm from patient hoists | A National Patient Safety Alert has been issued setting out practical steps to reduce the risk of harm when using patient hoists through improved checks and maintenance. |
| 2026-09-15 | MHRA announcement | MHRA and Malaysia strengthen partnership on healthcare innovation and research | The MHRA has reaffirmed its commitment to strengthening regulatory collaboration with Malaysia following high-level discussions in Kuala Lumpur. |
| 2026-09-10 | MHRA announcement | Independent Commission led by NHS doctors sets out blueprint to accelerate safe AI adoption in healthcare | New recommendations based on extensive public engagement set out how the NHS could give patients faster access to AI advances with proportionate safeguards to protect patient safety and maintain high levels of trust. |
| 2026-09-02 | ASA | ASA ruling on SheMed Ltd | The ASA ruled on a paid-for Reddit ad for SheMed, a female-focused medical weight-loss service, which promoted weight-loss prescription-only medicines to the public. A separate summary of the same ruling says it also covered emails and found the ads socially irresponsible, but only the Reddit ad description was confirmed on the ASA rulings listing. |
| 2026-09-02 | MHRA Drug Safety Update | Filters should be used during the administration of Parenteral Nutrition for patients in all care settings | Administration of parenteral nutrition without a filter has been associated with a number of adverse incidents including an embolism which resulted in a fatal outcome. |
| 2026-09-02 | MHRA announcement | MHRA and Manchester NHS partner on health innovation sandbox | New partnership to create health innovation sandbox that will test promising new technologies and build evidence to accelerate the safe adoption of technologies, including AI, in the NHS. |
| 2026-09-01 | MHRA announcement | MHRA concludes review of Avacopan Vifor following reassessment of benefit-risk balance | Avacopan Vifor is used in the treatment of some rare autoimmune diseases affecting small blood vessels. |
| 2026-09-01 | MHRA announcement | MHRA regulatory reform amendments tabled in Government’s Health Bill | Proposed amendments to support information sharing, regulatory reform and the future development of a medical device licensing regime. |
Source: gov.uk MHRA feeds plus a monthly web-search pass for ASA, Trading Standards and enforcement news
View as plain-text Markdown
### UK peptide regulation items for 2026-10, by date and source | Date | Source | Item | Summary | | --- | --- | --- | --- | | 2026-10-01 | MHRA announcement | MHRA joins global regulators in call to advance alternatives to animal testing | International statement co-developed by UK medicines regulator | | 2026-09-30 | MHRA announcement | DIA and MHRA announce speaker line-up for inaugural global summit | International leaders will gather to address some of the most significant opportunities and challenges facing healthcare today at the DIA-MHRA Global Summit. | | 2026-09-24 | MHRA announcement | MHRA welcomes sentencing after fraud convictions over falsely certified medical devices | Following convictions related to falsely certified medical devices, the MHRA has welcomed the sentencing in a long-running enforcement investigation. | | 2026-09-24 | MHRA announcement | Five new commissioners appointed to the Commission on Human Medicines (CHM) | The CHM provides independent expert advice to ministers on the safety, quality and efficacy of medicines. | | 2026-09-24 | MHRA announcement | Professor Dame Anna Dominiczak, Professor Alison Strath, and Fiona Cochrane: Catalysing the medicines ecosystem in Scotland | Scotland’s growing commercial research infrastructure and strong NHS, academic and industry partnerships are helping widen access to clinical trials, accelerate adoption and strengthen the UK life sciences ecosystem. | | 2026-09-23 | MHRA announcement | MHRA approves lurbinectedin for adults with extensive-stage small cell lung cancer | As with all licensed medicines, the MHRA will keep the safety and effectiveness of lurbinectedin under close review. | | 2026-09-22 | MHRA announcement | Funding opportunity launched to strengthen UK regulatory science and support healthcare innovation | Four new centres of excellence will bring together expertise across academia, industry, healthcare and regulation to keep pace with advances in healthcare and life sciences | | 2026-09-16 | MHRA announcement | MHRA sets out steps to prevent avoidable harm from patient hoists | A National Patient Safety Alert has been issued setting out practical steps to reduce the risk of harm when using patient hoists through improved checks and maintenance. | | 2026-09-15 | MHRA announcement | MHRA and Malaysia strengthen partnership on healthcare innovation and research | The MHRA has reaffirmed its commitment to strengthening regulatory collaboration with Malaysia following high-level discussions in Kuala Lumpur. | | 2026-09-10 | MHRA announcement | Independent Commission led by NHS doctors sets out blueprint to accelerate safe AI adoption in healthcare | New recommendations based on extensive public engagement set out how the NHS could give patients faster access to AI advances with proportionate safeguards to protect patient safety and maintain high levels of trust. | | 2026-09-02 | ASA | ASA ruling on SheMed Ltd | The ASA ruled on a paid-for Reddit ad for SheMed, a female-focused medical weight-loss service, which promoted weight-loss prescription-only medicines to the public. A separate summary of the same ruling says it also covered emails and found the ads socially irresponsible, but only the Reddit ad description was confirmed on the ASA rulings listing. | | 2026-09-02 | MHRA Drug Safety Update | Filters should be used during the administration of Parenteral Nutrition for patients in all care settings | Administration of parenteral nutrition without a filter has been associated with a number of adverse incidents including an embolism which resulted in a fatal outcome. | | 2026-09-02 | MHRA announcement | MHRA and Manchester NHS partner on health innovation sandbox | New partnership to create health innovation sandbox that will test promising new technologies and build evidence to accelerate the safe adoption of technologies, including AI, in the NHS. | | 2026-09-01 | MHRA announcement | MHRA concludes review of Avacopan Vifor following reassessment of benefit-risk balance | Avacopan Vifor is used in the treatment of some rare autoimmune diseases affecting small blood vessels. | | 2026-09-01 | MHRA announcement | MHRA regulatory reform amendments tabled in Government’s Health Bill | Proposed amendments to support information sharing, regulatory reform and the future development of a medical device licensing regime. | Source: gov.uk MHRA feeds plus a monthly web-search pass for ASA, Trading Standards and enforcement news
“MHRA rows come straight from a government feed and are as reliable as that feed. ASA, Trading Standards and Companies House rows come from a monthly search pass, which finds what is publicly indexed at the time it runs, not a comprehensive legal record. Treat an absence of ASA rulings in a given month as no ruling was published where our search looked, not as proof nothing happened.”
Director, PeptideClear UK
Previous months
- 2026-08: 24 items
Methodology
- MHRA rows: the same gov.uk news and communications feed and Drug Safety Update feed used on the MHRA tracker, filtered to the last 35 days.
- ASA, Trading Standards and Companies House rows: one scoped web-search pass, run once a month, asked specifically for peptide-advertising rulings, enforcement action naming a UK peptide retailer, and relevant CAP Code guidance. Only items with a real, checkable source URL are included.
- Cadence: this page updates once a month, not continuously. Check the fetch date below for currency.
- This replaces manual, ad hoc checking of ASA and enforcement news with a scheduled pass, but it is still a search of what is publicly indexed, not a subscription to a regulator's own alert system.
Last fetched 2026-10-02. PeptideClear is editorial. We do not prescribe, dispense or sell medicines.
Check it yourself: the official sources
PeptideClear is editorial. Nothing here replaces the regulator, and you should not take our word for any of it. These are the official UK destinations where the underlying position is published, free to read and open to anyone.
MHRA
MHRA Products portalThe Summary of Product Characteristics and Patient Information Leaflet for every medicine licensed in the UK. This is the authoritative document for what a medicine is licensed to do.
MHRA
Drug Safety UpdateThe MHRA monthly bulletin of safety advice for prescribers and patients. Where new risks and product information changes are formally announced.
MHRA
Report a fake or illegally supplied medicineThe MHRA route for reporting a website or seller supplying medicines illegally, and for reporting a product you believe is counterfeit.
Advertising Standards Authority
CAP Code and ASA rulingsThe UK advertising rules, including the ban on advertising prescription-only medicines to the public, and the published rulings that show how they are applied.
World Anti-Doping Agency
WADA Prohibited ListThe annually updated list of substances and methods banned in sport. Many research peptides sit under S0 or S2. UK Anti-Doping enforces it on tested athletes.
legislation.gov.uk
Human Medicines Regulations 2012The legislation that defines what counts as a medicine in the UK, and what constitutes illegal supply. A product marketed with medicinal claims is regulated as a medicine regardless of how it is labelled.
Our live data trackers
PeptideClear maintains these as refreshable datasets rather than one-off articles. Each carries its own source, methodology and last-updated date.
Live data tracker
UK GLP-1 prescribing tracker →
Monthly NHS England primary-care prescribing volumes for GLP-1 medications, rebuilt as each new month publishes. Dated chart, month-by-month table, full methodology.
Source: NHSBSA English Prescribing Dataset
Live data tracker
UK peptide clinical-trials tracker →
Registered interventional trials for every research peptide we track, by phase and recruitment status, linking through to each compound record.
Source: ClinicalTrials.gov and ISRCTN
Live data tracker
MHRA enforcement and safety tracker →
Every MHRA safety alert, enforcement action and drug safety update relevant to weight-loss medicines and peptides, dated and linked to the gov.uk original.
Source: gov.uk / MHRA
Live data tracker
UK research-peptide price index →
Headline price per milligram across the UK research-peptide retailers we score, so a price can be read against the market rather than in isolation.
Source: PeptideClear retailer survey
Live data tracker
PeptideClear Trust Index →
159 UK sellers assessed for free across three baseline measures (Testing Transparency, Business Transparency, Responsible Practice), independently, on the Which? / Defaqto model. Testing Transparency alone draws on six observable certificate-of-analysis signals, reproducible from the published data.
Source: PeptideClear methodology
Live data tracker
Data API and MCP server →
Read-only, no-auth REST API and MCP server over the full scored dataset: corporate identity, regulatory status, CoA verification signals. CC BY 4.0.
Source: PeptideClear, live data